Development of an LC-MS/MS method for determining 5-MeO-DIPT in dried urine spots and application to forensic cases

J Forensic Leg Med. 2020 May:72:101963. doi: 10.1016/j.jflm.2020.101963. Epub 2020 Apr 12.

Abstract

Purpose: The dried urine spots (DUSs) technique is increasing continuously as an easy sampling method for monitoring substance abuse due to its advantages of stability and convenience regarding transport and storage. 5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a new type of tryptamine hallucinogen, the use of which has been banned in many countries. And according to the previous research, 5-MeO-DIPT is not stable in urine. In order to improve its stability, an LC-MS/MS method for determining 5-MeO-DIPT in DUSs was developed.

Method: 10 μl urine was spotted on Whatman FTATM classic card, then extracted with 200 μl methanol, and liquid chromatography-tandem mass spectrometry in positive ion multiple reaction monitoring mode was utilized for analysis.

Results: The LOD and LLOQ of the method were 0.1 ng/ml and 0.2 ng/ml, respectively. The accuracy and precision were 98.2%-103.9% and 2.7%-8.5%, respectively. It was found that the stability of 5-MeO-DIPT in DUSs was better than the stability of 5-MeO-DIPT in urine stored at 25 °C. Moreover, this method was also applied to detect 5-MeO-DIPT in the urine of individuals known to have used 5-MeO-DIPT. It was found that the concentrations of 5-MeO-DIPT were 0.3-2.3 ng/ml, which were lower than those obtained via GC-Orbitrap-MS. The small volume of urine required (10 μl), combined with the simplicity of the analytical technique, makes this an useful procedure for the screening of drug of abuse.

Keywords: 5-MeO-DIPT; Dried urine spots; Drug abuse; LC-MS/MS; Monitoring.

MeSH terms

  • 5-Methoxytryptamine / analogs & derivatives*
  • 5-Methoxytryptamine / urine
  • Chromatography, Liquid / methods*
  • Desiccation
  • Drug Stability
  • Forensic Toxicology / methods
  • Hallucinogens / urine*
  • Humans
  • Limit of Detection
  • Substance Abuse Detection*
  • Substance-Related Disorders / urine*
  • Tandem Mass Spectrometry / methods*

Substances

  • Hallucinogens
  • 5-methoxy-N,N-diisopropyltryptamine
  • 5-Methoxytryptamine